Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus

D M Wilson1, J A Luetscher

  • 1Department of Pediatrics, Stanford University School of Medicine, Calif.

Insights

Elevated plasma prorenin activity can predict future microvascular complications like retinopathy and nephropathy in young patients with Type I diabetes. This finding helps identify at-risk individuals for early intervention.

Area of Science:

  • Endocrinology
  • Nephrology
  • Ophthalmology

Background:

  • Renin, a hormone precursor, is produced by kidney juxtaglomerular cells.
  • Elevated plasma prorenin activity is observed in Type I diabetes patients with microvascular complications.
  • This study investigated prorenin activity as a predictor of complications in young Type I diabetes patients.

Purpose of the Study:

  • To prospectively assess if rising plasma prorenin activity predicts the development of microvascular complications.
  • To evaluate plasma prorenin activity as a risk marker in pediatric and adolescent Type I diabetes.

Main Methods:

  • Plasma prorenin activity was measured in 135 children and adolescents with Type I diabetes.
  • Patients were monitored for retinopathy and albuminuria over a follow-up period.
  • Longitudinal measurements of plasma prorenin and urinary albumin were conducted.

Main Results:

  • Plasma prorenin activity was significantly higher in patients with retinopathy or albuminuria compared to controls.
  • In patients with uncomplicated diabetes, consistently normal prorenin levels were associated with a low incidence of complications.
  • High prorenin values preceded the development of retinopathy or albuminuria by at least 18 months in 8 out of 14 patients.

Conclusions:

  • Increased plasma prorenin activity is a significant indicator of high risk for retinopathy and nephropathy.
  • Plasma prorenin activity can identify young diabetic patients who will develop microvascular complications.
  • Prorenin measurement offers a predictive tool for managing diabetic complications.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...